246 related articles for article (PubMed ID: 38159713)
1. Exploring microalgal and cyanobacterial metabolites with antiprotozoal activity against Leishmania and Trypanosoma parasites.
Matos ÂP; Saldanha-Corrêa FMP; Gomes RDS; Hurtado GR
Acta Trop; 2024 Mar; 251():107116. PubMed ID: 38159713
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
[TBL] [Abstract][Full Text] [Related]
3. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
[TBL] [Abstract][Full Text] [Related]
4. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Potential of Flavonoid Derivatives for Certain Neglected Tropical Diseases.
Pone BK; Ferreira EI
Curr Drug Targets; 2022; 23(7):680-682. PubMed ID: 35264087
[TBL] [Abstract][Full Text] [Related]
6. Novel compounds to combat trypanosomatid infections: a medicinal chemical perspective.
González M; Cerecetto H
Expert Opin Ther Pat; 2011 May; 21(5):699-715. PubMed ID: 21428846
[TBL] [Abstract][Full Text] [Related]
7. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles.
Nweze JA; Mbaoji FN; Li YM; Yang LY; Huang SS; Chigor VN; Eze EA; Pan LX; Zhang T; Yang DF
Infect Dis Poverty; 2021 Jan; 10(1):9. PubMed ID: 33482912
[TBL] [Abstract][Full Text] [Related]
8. Screening a Natural Product-Based Library against Kinetoplastid Parasites.
Zulfiqar B; Jones AJ; Sykes ML; Shelper TB; Davis RA; Avery VM
Molecules; 2017 Oct; 22(10):. PubMed ID: 29023425
[TBL] [Abstract][Full Text] [Related]
9. Anilinoquinoline based inhibitors of trypanosomatid proliferation.
Ferrins L; Sharma A; Thomas SM; Mehta N; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Gillingwater K; Pollastri MP
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006834. PubMed ID: 30475800
[TBL] [Abstract][Full Text] [Related]
10. Antiprotozoal compounds from Mikania periplocifolia (Asteraceae).
Laurella LC; Elso OG; Rodriguez RN; Viecenz JM; Alonso MR; Bontempi EJ; Malchiodi E; Catalán CAN; Cazorla SI; Sülsen VP
Fitoterapia; 2023 Jun; 167():105499. PubMed ID: 37019368
[TBL] [Abstract][Full Text] [Related]
11. Biological evaluation and structure-activity relationships of imidazole-based compounds as antiprotozoal agents.
Saccoliti F; Madia VN; Tudino V; De Leo A; Pescatori L; Messore A; De Vita D; Scipione L; Brun R; Kaiser M; Mäser P; Calvet CM; Jennings GK; Podust LM; Costi R; Di Santo R
Eur J Med Chem; 2018 Aug; 156():53-60. PubMed ID: 30006174
[TBL] [Abstract][Full Text] [Related]
12. Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis.
Lorente SO; Rodrigues JC; Jiménez Jiménez C; Joyce-Menekse M; Rodrigues C; Croft SL; Yardley V; de Luca-Fradley K; Ruiz-Pérez LM; Urbina J; de Souza W; González Pacanowska D; Gilbert IH
Antimicrob Agents Chemother; 2004 Aug; 48(8):2937-50. PubMed ID: 15273104
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
Orosco D; Mendoza AR; Meléndez CM
Curr Top Med Chem; 2024; 24(2):89-108. PubMed ID: 37842892
[TBL] [Abstract][Full Text] [Related]
14. Anti-leishmanial and anti-trypanosomal natural products from endophytes.
Hzounda Fokou JB; Dize D; Etame Loe GM; Nko'o MHJ; Ngene JP; Ngoule CC; Boyom FF
Parasitol Res; 2021 Mar; 120(3):785-796. PubMed ID: 33409640
[TBL] [Abstract][Full Text] [Related]
15. Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies.
Tasdemir D; Kaiser M; Brun R; Yardley V; Schmidt TJ; Tosun F; Rüedi P
Antimicrob Agents Chemother; 2006 Apr; 50(4):1352-64. PubMed ID: 16569852
[TBL] [Abstract][Full Text] [Related]
16. Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis.
Lepesheva GI; Waterman MR
Curr Top Med Chem; 2011; 11(16):2060-71. PubMed ID: 21619513
[TBL] [Abstract][Full Text] [Related]
17. In vitro antiprotozoal activity of (S)-cis-Verbenol against Leishmania spp. and Trypanosoma cruzi.
Yaluff G; Vega C; Alvarenga N
Acta Trop; 2017 Apr; 168():41-44. PubMed ID: 28062234
[TBL] [Abstract][Full Text] [Related]
18. Search for Antiprotozoal Activity in Herbal Medicinal Preparations; New Natural Leads against Neglected Tropical Diseases.
Llurba Montesino N; Kaiser M; Brun R; Schmidt TJ
Molecules; 2015 Aug; 20(8):14118-38. PubMed ID: 26248069
[TBL] [Abstract][Full Text] [Related]
19. Germacranolide-type sesquiterpene lactones from Smallanthus sonchifolius with promising activity against Leishmania mexicana and Trypanosoma cruzi.
Ulloa JL; Spina R; Casasco A; Petray PB; Martino V; Sosa MA; Frank FM; Muschietti LV
Parasit Vectors; 2017 Nov; 10(1):567. PubMed ID: 29132413
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the in vitro antiprotozoal and cytotoxic potential of 20 selected medicinal plants from the island of Soqotra.
Mothana RA; Al-Musayeib NM; Matheeussen A; Cos P; Maes L
Molecules; 2012 Dec; 17(12):14349-60. PubMed ID: 23208469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
